---
title: "Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293935626.md"
description: "Kuehn Law, PLLC is investigating Kymera Therapeutics, Inc. for potential breaches of fiduciary duties and self-dealing by officers and directors. The firm encourages long-term KYMR shareholders to contact them for free consultations regarding potential damages and governance reforms, noting that time limits may apply."
datetime: "2026-07-27T12:49:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293935626.md)
  - [en](https://longbridge.com/en/news/293935626.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293935626.md)
---

# Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm

NEW YORK, July 27, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of **Kymera Therapeutics, Inc. ()** breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are **a long-term** **KYMR stockholder** please contact Sophia Anne Silayan by email at sophiaanne@kuehn.law or call (833) 672-0814. **The consultation and case are free with no obligation to you.** **Kuehn Law pays all case costs and does not charge its investor clients.** _Shareholders should contact the firm immediately as there may be limited time to enforce your rights._

**Why Your Participation Matters:**

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. _Your investment. Your voice. Your future._™

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:

Kuehn Law, PLLC

Justin Kuehn, Esq.

53 Hill Street, Suite 605

Southampton, NY 11968

justin@kuehn.law

(833) 672-0814

SOURCE Kuehn Law, PLLC

### Related Stocks

- [KYMR.US](https://longbridge.com/en/quote/KYMR.US.md)

## Related News & Research

- [Kymera Therapeutics files initial beneficial ownership statement for Chief Medical Officer Terence Rooney](https://longbridge.com/en/news/293980665.md)
- [Kymera Therapeutics names Terence Rooney chief medical officer as Jared Gollob retires](https://longbridge.com/en/news/293968691.md)
- [Kuehn Law Encourages Investors of SailPoint, Inc. to Contact Law Firm](https://longbridge.com/en/news/293935906.md)
- [Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm](https://longbridge.com/en/news/293935644.md)
- [First Choice Healthcare Solutions, Inc. Information on Share Consolidation | FCHS Stock News](https://longbridge.com/en/news/293646722.md)